222 related articles for article (PubMed ID: 22804716)
1. Amphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalization.
German CL; Hanson GR; Fleckenstein AE
J Neurochem; 2012 Oct; 123(2):288-97. PubMed ID: 22804716
[TBL] [Abstract][Full Text] [Related]
2. Rapid substrate-induced down-regulation in function and surface localization of dopamine transporters: rat dorsal striatum versus nucleus accumbens.
Richards TL; Zahniser NR
J Neurochem; 2009 Mar; 108(6):1575-84. PubMed ID: 19183252
[TBL] [Abstract][Full Text] [Related]
3. Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo.
Goodwin JS; Larson GA; Swant J; Sen N; Javitch JA; Zahniser NR; De Felice LJ; Khoshbouei H
J Biol Chem; 2009 Jan; 284(5):2978-2989. PubMed ID: 19047053
[TBL] [Abstract][Full Text] [Related]
4. Methamphetamine self-administration acutely decreases monoaminergic transporter function.
McFadden LM; Stout KA; Vieira-Brock PL; Allen SC; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
Synapse; 2012 Mar; 66(3):240-5. PubMed ID: 22120988
[TBL] [Abstract][Full Text] [Related]
5. Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation.
Johnson LA; Furman CA; Zhang M; Guptaroy B; Gnegy ME
Neuropharmacology; 2005 Nov; 49(6):750-8. PubMed ID: 16212991
[TBL] [Abstract][Full Text] [Related]
6. Single and binge methamphetamine administrations have different effects on the levels of dopamine D2 autoreceptor and dopamine transporter in rat striatum.
Chauhan H; Killinger BA; Miller CV; Moszczynska A
Int J Mol Sci; 2014 Apr; 15(4):5884-906. PubMed ID: 24717411
[TBL] [Abstract][Full Text] [Related]
7. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
8. Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms.
Cervinski MA; Foster JD; Vaughan RA
J Biol Chem; 2005 Dec; 280(49):40442-9. PubMed ID: 16204245
[TBL] [Abstract][Full Text] [Related]
9. Repeated administration of D-amphetamine induces loss of [123I]FP-CIT binding to striatal dopamine transporters in rat brain: a validation study.
Booij J; de Bruin K; Gunning WB
Nucl Med Biol; 2006 Apr; 33(3):409-11. PubMed ID: 16631090
[TBL] [Abstract][Full Text] [Related]
10. Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.
Sandoval V; Riddle EL; Ugarte YV; Hanson GR; Fleckenstein AE
J Neurosci; 2001 Feb; 21(4):1413-9. PubMed ID: 11160413
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes.
Midde NM; Gomez AM; Zhu J
J Neuroimmune Pharmacol; 2012 Sep; 7(3):629-39. PubMed ID: 22570010
[TBL] [Abstract][Full Text] [Related]
12. Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.
McFadden LM; Hadlock GC; Allen SC; Vieira-Brock PL; Stout KA; Ellis JD; Hoonakker AJ; Andrenyak DM; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2012 Feb; 340(2):295-303. PubMed ID: 22034657
[TBL] [Abstract][Full Text] [Related]
13. Amphetamine Induces Sex-Dependent Loss of the Striatal Dopamine Transporter in Sensitized Mice.
Bagalkot T; Sorkin A
eNeuro; 2024 Jan; 11(1):. PubMed ID: 38164591
[TBL] [Abstract][Full Text] [Related]
14. Dopamine transporter phosphorylation site threonine 53 is stimulated by amphetamines and regulates dopamine transport, efflux, and cocaine analog binding.
Challasivakanaka S; Zhen J; Smith ME; Reith MEA; Foster JD; Vaughan RA
J Biol Chem; 2017 Nov; 292(46):19066-19075. PubMed ID: 28939767
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.
Hadlock GC; Baucum AJ; King JL; Horner KA; Cook GA; Gibb JW; Wilkins DG; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2009 Apr; 329(1):169-74. PubMed ID: 19141713
[TBL] [Abstract][Full Text] [Related]
16. Dopamine transporter activity mediates amphetamine-induced inhibition of Akt through a Ca2+/calmodulin-dependent kinase II-dependent mechanism.
Wei Y; Williams JM; Dipace C; Sung U; Javitch JA; Galli A; Saunders C
Mol Pharmacol; 2007 Mar; 71(3):835-42. PubMed ID: 17164407
[TBL] [Abstract][Full Text] [Related]
17. Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism.
Baucum AJ; Rau KS; Riddle EL; Hanson GR; Fleckenstein AE
J Neurosci; 2004 Mar; 24(13):3436-43. PubMed ID: 15056723
[TBL] [Abstract][Full Text] [Related]
18. Direct and Systemic Administration of a CNS-Permeant Tamoxifen Analog Reduces Amphetamine-Induced Dopamine Release and Reinforcing Effects.
Carpenter C; Zestos AG; Altshuler R; Sorenson RJ; Guptaroy B; Showalter HD; Kennedy RT; Jutkiewicz E; Gnegy ME
Neuropsychopharmacology; 2017 Sep; 42(10):1940-1949. PubMed ID: 28492278
[TBL] [Abstract][Full Text] [Related]
19. Effects of subchronic methamphetamine exposure on basal dopamine and stress-induced dopamine release in the nucleus accumbens shell of rats.
Broom SL; Yamamoto BK
Psychopharmacology (Berl); 2005 Sep; 181(3):467-76. PubMed ID: 15986185
[TBL] [Abstract][Full Text] [Related]
20. Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activation.
Hadlock GC; Chu PW; Walters ET; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2010 Oct; 335(1):207-12. PubMed ID: 20622144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
